Skip to main navigation Skip to search Skip to main content

Findings from Hospital Pablo Tobon Uribe in the Area of Type 2 Diabetes Reported (Dose-Response and Clinical Equivalence of Semaglutide and Tirzepatide for Weight Loss in Type 2 Diabetes: A Model-Based Analysis)

Press/Media: Press / Media

PeriodJun 18 2026

Media coverage

1

Media coverage

  • TitleFindings from Hospital Pablo Tobon Uribe in the Area of Type 2 Diabetes Reported (Dose-Response and Clinical Equivalence of Semaglutide and Tirzepatide for Weight Loss in Type 2 Diabetes: A Model-Based Analysis)
    Media name/outletClinical Trials Daily
    Date6/18/26
    PersonsAdriana Alzate Echeverri